E2F1 drives chemotherapeutic drug resistance via ABCG2

M. T. Rosenfeldt; L. A. Bell; J. S. Long; J. O'Prey; C. Nixon; F. Roberts; C. Dufès; K. M. Ryan

doi:10.1038/onc.2013.470

E2F1 drives chemotherapeutic drug resistance via ABCG2

M. T. Rosenfeldt, L. A. Bell, J. S. Long, J. O'Prey, C. Nixon, F. Roberts, C. Dufès, K. M. Ryan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4164-4172
Number of pages	9
Journal	Oncogene
Volume	33
Issue number	32
DOIs	https://doi.org/10.1038/onc.2013.470
Publication status	Published - Aug 7 2014
Externally published	Yes

ASJC Scopus Subject Areas

Genetics
Molecular Biology
Cancer Research

Keywords

ABCG2
E2F1
cancer
drug sensitivity
multidrug transporters

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/onc.2013.470

Cite this

Rosenfeldt, M. T., Bell, L. A., Long, J. S., O'Prey, J., Nixon, C., Roberts, F., Dufès, C., & Ryan, K. M. (2014). E2F1 drives chemotherapeutic drug resistance via ABCG2. Oncogene, 33(32), 4164-4172. https://doi.org/10.1038/onc.2013.470

@article{c1689cfef66e4049bd5db433240ac85a,

title = "E2F1 drives chemotherapeutic drug resistance via ABCG2",

keywords = "ABCG2, E2F1, cancer, drug sensitivity, multidrug transporters",

author = "Rosenfeldt, {M. T.} and Bell, {L. A.} and Long, {J. S.} and J. O'Prey and C. Nixon and F. Roberts and C. Duf{\`e}s and Ryan, {K. M.}",

note = "Funding Information: This work was supported by Association for International Cancer Research and Cancer Research UK, and by a Wellcome trust equipment grant (ME0442) to CD. We thank Doron Ginsberg, Kristian Helin, Douglas Ross and Karen Vousden for reagents.",

year = "2014",

month = aug,

day = "7",

doi = "10.1038/onc.2013.470",

language = "English",

volume = "33",

pages = "4164--4172",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "32",

}

TY - JOUR

T1 - E2F1 drives chemotherapeutic drug resistance via ABCG2

AU - Rosenfeldt, M. T.

AU - Bell, L. A.

AU - Long, J. S.

AU - O'Prey, J.

AU - Nixon, C.

AU - Roberts, F.

AU - Dufès, C.

AU - Ryan, K. M.

N1 - Funding Information: This work was supported by Association for International Cancer Research and Cancer Research UK, and by a Wellcome trust equipment grant (ME0442) to CD. We thank Doron Ginsberg, Kristian Helin, Douglas Ross and Karen Vousden for reagents.

PY - 2014/8/7

Y1 - 2014/8/7

KW - ABCG2

KW - E2F1

KW - cancer

KW - drug sensitivity

KW - multidrug transporters

UR - http://www.scopus.com/inward/record.url?scp=84905822307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905822307&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.470

DO - 10.1038/onc.2013.470

M3 - Article

C2 - 24276245

AN - SCOPUS:84905822307

SN - 0950-9232

VL - 33

SP - 4164

EP - 4172

JO - Oncogene

JF - Oncogene

IS - 32

ER -

E2F1 drives chemotherapeutic drug resistance via ABCG2

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this